UK investigates drugs distribution market

The UK's Office of Fair Trading (OFT) today launched an investigation into the impact on the cost of medicines to patients and the NHS after Pfizer’s controversial deal to sell drugs in the UK solely through one wholesaler.

The Government watchdog is to put the drugs distribution market under the microscope in a bid to ensure patients and the health service will continue to get a fair deal as the sector consolidates.